X Square Capital LLC Buys New Position in Semler Scientific, Inc. (NASDAQ:SMLR)

X Square Capital LLC purchased a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 23,025 shares of the company’s stock, valued at approximately $1,243,000. X Square Capital LLC owned about 0.25% of Semler Scientific as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of SMLR. Jones Financial Companies Lllp bought a new position in Semler Scientific during the fourth quarter worth $34,000. Larson Financial Group LLC acquired a new stake in Semler Scientific during the 4th quarter worth about $38,000. IFP Advisors Inc acquired a new stake in Semler Scientific during the 4th quarter worth about $54,000. Quest Partners LLC raised its position in shares of Semler Scientific by 48.0% in the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after acquiring an additional 817 shares in the last quarter. Finally, Global Retirement Partners LLC increased its holdings in Semler Scientific by 62.5% in the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock worth $70,000 after purchasing an additional 500 shares in the last quarter. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Trading Down 6.7 %

NASDAQ:SMLR opened at $36.92 on Friday. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $81.56. The stock has a market capitalization of $354.32 million, a price-to-earnings ratio of 7.52 and a beta of 1.33. The firm has a fifty day simple moving average of $46.02 and a two-hundred day simple moving average of $44.53.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. The firm had revenue of $12.41 million during the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.

Analyst Ratings Changes

Separately, Lake Street Capital increased their price target on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, January 24th.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.